Carregant...
The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice
The prevalence of immune-mediated liver diseases such as autoimmune liver disease or viral hepatitis has increased in recent years, and the side effects of pre-existing treatments are a worldwide problem. Regulatory T cells (Tregs) and T helper 17 (Th17) cells play important roles in the development...
Guardat en:
| Publicat a: | Mol Med Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854585/ https://ncbi.nlm.nih.gov/pubmed/31638166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10750 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|